Drug intelligence / Profile preview

ketamine + sevoflurane

Development stage
Unknown
Modality
Small Molecules
Administration
Intravenous, Intramuscular, Inhalation
01

Overview

Ketamine + sevoflurane is an anesthetic combination used for induction and maintenance of general anesthesia. Ketamine (typically administered intravenously or intramuscularly) is used for induction, while sevoflurane (an inhalational anesthetic) is used for maintenance. This combination provides safe, effective, and controllable anesthesia in various patient populations, including injured loggerhead sea turtles, children undergoing cardiac procedures, and patients requiring general anesthesia for surgical procedures[1][4]. The combination offers several advantages: - Provides stable hemodynamics during anesthesia induction and intubation[5] - Reduces the risk of bronchospasm in asthmatic children[3] - Allows for controlled anesthesia with predictable recovery times[4] - Maintains adequate analgesia while providing muscle relaxation when needed[1][8] Ketamine acts primarily as an NMDA receptor antagonist, producing dissociative anesthesia characterized by profound analgesia, normal pharyngeal-laryngeal reflexes, and cardiovascular stimulation[8]. Sevoflurane works by enhancing inhibitory postsynaptic channel activity by binding to GABA receptors and inhibiting excitatory synaptic channel activity[2].

02

Targets

NMDAR (Glutamate receptor ionotropic, NMDA)GLRA1 (Glycine receptor subunit Alpha-1)

Beyond the preview

Go deeper on ketamine + sevoflurane.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on ketamine + sevoflurane.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call